O

Ocuphire Pharma

20 employees

Ocuphire Pharma, a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Biopharma

Date founded

2018

Funding rounds raised

Total raised

$15M

from 9 investors over 9 rounds

O

Ocuphire Pharma raised $15M on June 8, 2021

Investors: Lincoln Park Capital, LLC, Ayrton Capital and Altium Capital

O

Ocuphire Pharma raised $1.7M on November 16, 2020

Investors: National Eye Institute (NEI)

O

Ocuphire Pharma raised $5M on July 22, 2019

Investors: BELLE Capital USA LP, Woodward Angels, BlueWater Angels, Grand Angels and Michigan Angel Fund

FAQ